Eye Health News and Research

Latest Eye Health News and Research

Tiny microneedles to treat macular degeneration

Thanks to tiny microneedles, eye doctors may soon have a better way to treat diseases such as macular degeneration that affect tissues in the back of the eye. That could be important as the population ages and develops more eye-related illnesses - and as pharmaceutical companies develop new drugs that otherwise could only be administered by injecting into the eye with a hypodermic needle.

23 Jul 2012

Insights on neural mechanisms behind guidance of attention

Ever wonder how the human brain, which is constantly bombarded with millions of pieces of visual information, can filter out what's unimportant and focus on what's most useful?

23 Jul 2012

Noted philanthropist to launch mobile eye clinic in North India

Noted entrepreneur and philanthropist, Tej Kohli is all set to launch Drishti Rath, a complete eye clinic on wheels. After the successful launch of the corneal blindness eradication programme in 2010, which enabled hundreds of poverty stricken corneal blind to get vision and which is still running successfully across NCR and neighbouring rural areas, Tej is set to launch this first-of-its-kind initiative in North India.

23 Jul 2012

Foundation Fighting Blindness grants US$125,000 to Oxford BioMedica for UshStat Phase I/IIa trial

Oxford BioMedica plc, the leading gene-based biopharmaceutical company, today announces that the US non-profit organisation, the Foundation Fighting Blindness (FFB), has granted an award of US$125,000 to the Company via its translational research arm, the Foundation Fighting Blindness Clinical Research Institute (FFBCRI) formerly known as the National Neurovision Research Institute (NNRI).

23 Jul 2012

BioDiem presents positive findings of their eye disease drug at international conference

Australian infectious disease therapy and vaccine development company BioDiem Ltd (ASX: BDM) today announced positive results from formal studies of its BDM-E eye disease drug, presented over 21 – 22 July at the International Society for Eye Research (ISER) meeting in Berlin, Germany. The ISER convenes leading researchers and clinicians in the area of eye disease.

22 Jul 2012

State roundup: Texas Medicaid fraud probes use controversial tool

When it comes to finding cost savings in the state's unwieldy Medicaid program, the Health and Human Services Commission's Office of Inspector General gets high marks. … But OIG's dollar-recovery strategy -- which includes an increased reliance on a rule that allows investigators to freeze financing for any health provider accused of overbilling -- has enraged doctors, dentists and other providers who treat Medicaid patients.

21 Jul 2012

Second Sight’s Argus II Retinal Prosthesis System scheduled for FDA panel review

Second Sight Medical Products Inc., the world's leading developer and manufacturer of retinal prostheses, today announced that a U.S. Food and Drug Administration (FDA) Ophthalmic Devices Advisory Panel has been scheduled to review the data presented in the company's Humanitarian Device Exemption (HDE) market approval application for its Argus II Retinal Prosthesis System (Argus II prosthesis) on September 28, 2012 in Gaithersburg, Maryland.

21 Jul 2012

In Florida, Obama attacks Romney on Medicare plan

Drawing on traditional Democratic campaign themes, President Barack Obama criticized GOP plans to transform Medicare into a "voucher program" and to repeal the 2010 health law.

21 Jul 2012

Number of blind persons decline in Germany

The numbers of people in Germany who are blind or visually impaired is going down. Robert P. Finger and his co-authors present their findings in the current edition of Deutsches -rzteblatt International.

21 Jul 2012

RPB awards $110,000 grant to Mass. Eye and Ear and HMS for research into blinding diseases

Research to Prevent Blindness (RPB) has awarded a grant of $110,000 to the Massachusetts Eye and Ear Infirmary to support research into the causes, treatment and prevention of blinding diseases. The research will be directed by Joan W. Miller, M.D., Chief of the Mass. Eye and Ear and Mass. General Hospital's Departments of Ophthalmology and Chair of the Department of Ophthalmology at Harvard Medical School.

21 Jul 2012

Views on health reform: U.S. not getting value for its spending; Cutting doctors' school debt to curb costs

When it comes to healthcare, Americans are not getting a lot of value for their money. The United States spends 17.6% of its gross domestic product, nearly twice the average of the nations in the Organization for Economic Cooperation and Development. But life expectancy in the United States in 2010, at 78.7 years, is below the OECD average of 79.8 years. The U.S. infant mortality rate is higher than in most developed countries - it is higher than the rates in Greece, Hungary and Slovakia.

21 Jul 2012

Ablation technique destroys eye of the storm

Researchers have developed a new technology that could significantly improve the success rate of procedures to treat atrial fibrillation.

20 Jul 2012

Risk factors defined for retinal detachment after cataract surgery

Study results spanning 22 years show that the risk for retinal detachment after undergoing phacoemulsification for cataracts has fallen dramatically, but that younger, and male patients are more at risk for this adverse outcome than their older, female peers.

20 Jul 2012

FDA clears pSivida's IND for injectable sustained-release micro-insert to treat posterior uveitis

pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application to treat posterior uveitis with pSivida's injectable sustained-release micro-insert.

20 Jul 2012

TLC announces first Laser Cataract Surgeries to be performed in Canada

TLC Laser Eye Centers is excited to announce the first Laser Cataract Surgeries to be performed in Canada, using an approved femtosecond laser, will take place at TLC's Mississauga center on July 24, 2012.

20 Jul 2012

BioDiem signs agreement with RMIT to create new non-influenza vaccines

Australian infectious disease therapy and vaccine development company BioDiem Ltd (ASX: BDM) today announced that BioDiem has signed an agreement with The Royal Melbourne Institute of Technology (RMIT) regarding a research program that will investigate the use of BioDiem’s live attenuated influenza virus (LAIV) to create new non-influenza vaccines. Developing the potential of the LAIV technology for new indications is an important part of BioDiem’s strategy, and this research is part of the work towards that goal.

19 Jul 2012

Otsuka, Acucela commence rebamipide ophthalmic suspension Phase 3 trial in dry eye syndrome

Acucela Inc., a clinical stage biotechnology company focused on developing new treatments for blinding eye diseases, and Otsuka Pharmaceutical Co., Ltd., today announced the initiation of a Phase 3 clinical trial to evaluate rebamipide ophthalmic suspension in patients with dry eye syndrome.

19 Jul 2012

Six young scientists to receive 2012 Klerman and Freedman Awards

Six young scientists will be recognized with the Annual Klerman and Freedman Awards by the Brain & Behavior Research Foundation on Friday July 27, 2012 at Le Parker Meriden Hotel in New York City on Friday, July 27.

18 Jul 2012

U.S. News & World Report names U-M among 2012 America's Best Hospitals

The University of Michigan Hospitals and Health Centers offer the best care in Michigan and some of the nation's best care, according to a new ranking from U.S. News & World Report.

18 Jul 2012

Glaucoma monitoring important in corneal dystrophy

The prevalence of glaucoma and/or ocular hypertension is more frequent in individuals with severe Fuchs’ endothelial corneal dystrophy than those without the condition, suggesting the importance of glaucoma screening in such patients, suggest US researchers.

18 Jul 2012

Eye Health News and Research

Latest Eye Health News and Research

Tiny microneedles to treat macular degeneration

Insights on neural mechanisms behind guidance of attention

Noted philanthropist to launch mobile eye clinic in North India

Foundation Fighting Blindness grants US$125,000 to Oxford BioMedica for UshStat Phase I/IIa trial

BioDiem presents positive findings of their eye disease drug at international conference

State roundup: Texas Medicaid fraud probes use controversial tool

Second Sight’s Argus II Retinal Prosthesis System scheduled for FDA panel review

In Florida, Obama attacks Romney on Medicare plan

Number of blind persons decline in Germany

RPB awards $110,000 grant to Mass. Eye and Ear and HMS for research into blinding diseases

Views on health reform: U.S. not getting value for its spending; Cutting doctors' school debt to curb costs

Ablation technique destroys eye of the storm

Risk factors defined for retinal detachment after cataract surgery

FDA clears pSivida's IND for injectable sustained-release micro-insert to treat posterior uveitis

TLC announces first Laser Cataract Surgeries to be performed in Canada

BioDiem signs agreement with RMIT to create new non-influenza vaccines

Otsuka, Acucela commence rebamipide ophthalmic suspension Phase 3 trial in dry eye syndrome

Six young scientists to receive 2012 Klerman and Freedman Awards

U.S. News & World Report names U-M among 2012 America's Best Hospitals

Glaucoma monitoring important in corneal dystrophy

Event guide: The 4th Ophthalmic Drug Delivery Summit eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Eye Health News and Research

Latest Eye Health News and Research

Event guide: The 4th Ophthalmic Drug Delivery Summit eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in